Transcutaneous immunization using SLA or rLACK skews the immune response towards a Th1 profile but fails to protect BALB/c mice against a Leishmania major challenge

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2019
Source ID
10.1016/j.vaccine.2018.11.052

Entities

People

  • Carl R. Alving
  • Elaine B. Morrison
  • Inès Lakhal-Naouar
  • John M. Childs
  • Mangala Rao
  • Nancy Koles
  • Naomi E. Aronson

Organizations

  • Henry M. Jackson Foundation for the Advancement of Military Medicine
  • Uniformed Services University of the Health Sciences